De novo CD5+ diffuse large B cell lymphoma with basophilia in the peripheral blood: Successful treatment with autologous peripheral blood stem cell transplantation

American Journal of Hematology

Volumn 82, Issue 2, 2007, Pages 162-167

  Tokuhira, Michihide ^a   Watanabe, Reiko ^a   Iizuka, Atsushi ^a   Sekiguchi, Yasunobu ^a   Nemoto, Tomoe ^a   Hanzawa, Kyoto ^a   Takamatsu, Ichiro ^b   Maruyama, Taro ^b   Tamaru, Jun Ichi ^a   Itoyama, Shinji ^a   Suzuki, Hiroshi ^c   Takeuchi, Tsutomu ^a   Mori, Shigehisa ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b SAITAMA SOCIAL INSURANCE HOSPITAL   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Autologous peripheral blood stem cell transplantation; Basophilia; CD5; Diffuse large B cell lymphoma

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CISPLATIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2 RECEPTOR ALPHA; PREDNISOLONE; RANIMUSTINE; VINCRISTINE;

ADULT; ALLERGY; ARTICLE; ASCITES; AUTOLOGOUS BONE MARROW TRANSPLANTATION; B CELL LYMPHOMA; BASOPHILIA; CASE REPORT; DRUG MEGADOSE; HUMAN; INFLAMMATION; IRON DEFICIENCY ANEMIA; LARGE CELL LYMPHOMA; LYMPHADENOPATHY; MALE; MYELOPROLIFERATIVE DISORDER; PARAAORTIC LYMPH NODE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLEURA EFFUSION; PRIORITY JOURNAL; REMISSION; SMALL INTESTINE TUMOR;

ADULT; ANTIGENS, CD5; ASCITES; ASIAN CONTINENTAL ANCESTRY GROUP; BASOPHILS; HUMANS; INTESTINAL NEOPLASMS; JAPAN; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLEURAL EFFUSION, MALIGNANT; REMISSION INDUCTION; TRANSPLANTATION, AUTOLOGOUS; TUMOR BURDEN;

EID: 33846497904     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20786     Document Type: Article

References (19)

1. Arock M, Schneider E, Boissan M, Tricottet V, Dy M. Differentiation of human basophils: An overview of recent advances and pending questions. J Leukoc Biol 2002;71:557-564.
2. Falcone FH, Haas H, Gibbs BF. The human basophil: A new appreciation of its role in immune responses. Blood 2000;96:4028-4038.
3. Dy M, Pacilio M, Arnould A, et al. Modulation of histidine decarboxylase activity and cytokine synthesis in human leukemic cell lines: Relationship with basophilic and/or megakaryocytic differentiation. Exp Hematol 1999;27:1295-1305.
4. Buhring HJ, Simmons PJ, Pudney M, et al. The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors. Blood 1999;94:2343-2356.
5. Yamaguchi M, Ohno T, Oka K, et al. De novo CD5-positive diffuse large B-cell lymphoma: Clinical characteristics and therapeutic outcome. Br J Hematol 1999;105:1133-1139.
6. Yamaguchi M, Seto M, Okamoto M, et al. De novo CD5+ diffuse large B-cell lymphoma: A clinicopathologic study of 109 patients. Blood 2002;99:815-821.
7. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511.
8. Colomo L, Lopez-Guillermo A, Perales M, et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood 2003;101:78-84.
9. Abramson JS, Shipp MA. Advances in the biology and therapy of diffuse large B-cell lymphoma: Moving toward a molecularly targeted approach. Blood 2005;106:1164-1174.
10. Kume M, Suzuki R, Yatabe Y, et al. Somatic hypermutations in the VH segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphomas. Jpn J Cancer Res 1997;88:1087-1093.
11. Taniguchi M, Oka K, Hiasa A, et al. De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood 1998;15:1145-1151.
12. Katzenberger T, Lohr A, Schwarz S, et al. Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell. Blood 2003;101:699-702.
13. Gasconye RD, Dave S, Zettle A, et al. Gene expressio microarray analysis of de novo CD5+ diffuse large cell lymphoma (LLMPP Study): A distinct entity? Blood 2003;101:178a. (abstract).
14. Karnan S, Tagawa H, Suzuki R, et al. Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 2004;39:77-81.
15. Tagawa H, Suguro M, Tsuzuki S, et al. Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma. Blood 2005;106:1770-1777.
16. Yoshioka T, Miura I, Kume M, et al. Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: Chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival. Genes Chromosomes Cancer 2005;42:149-157.
17. Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002;2:773-786.
18. Arnalich F, Lahoz C, Larrocha C, et al. Incidence and clinical significance of peripheral and bone marrow basophilia. J Med 1987;18:293-303.
19. May ME, Waddell CC. Basophils in peripheral blood and bone marrow. Am J Med 1984;76:509-511.